Axio Biosolutions Private

Founded in 2008, headquartered in Cambridge, Massachusetts, Axio is a ISO 13485 medical device company with focus on advanced wound care. Funded by Accel Partners, IDG Ventures, Axio uses innovative biopolymer based medical technology to create novel woundcare products. Its flagship product is Axiostat - a 100% chitosan haemostatic dressing that controls severe haemorrhage within minutes through its active adhesion to the trauma wound. The award winning CE approved product is being used in frontline battlefield by many defense forces across the globe.